Zimbus Breezhaler

· Novartis Europharm Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zimbus Breezhaler, covering 2025-10-30 to 2025-10-30. Get the full timeline:

Most recent: EMA Authorised: Zimbus Breezhaler (glycopyrronium bromide;Indacaterol (acetate);mometasone furoate) — Novartis Europharm Limited